Jennifer Luan

Title(s)Clinical Research Manager, HDF Comprehensive Cancer Ctr
SchoolSchool of Medicine
Address550 16th. Street
San Francisco CA 94158
Phone415-514-6220
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Radioembolization with 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study. J Gastrointest Oncol. 2016 Dec; 7(6):860-874. Fidelman N, Kerlan RK, Hawkins RA, Pampaloni M, Taylor AG, Kohi MP, Kolli KP, Atreya CE, Bergsland EK, Kelley RK, Ko AH, Korn WM, Van Loon K, McWhirter RM, Luan J, Johanson C, Venook AP. PMID: 28078110; PMCID: PMC5177572.
      View in: PubMed   Mentions: 9  
    2. Abstract No. 437 Radioembolization with 490Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study. Journal of Vascular and Interventional Radiology. 2015 Feb 1; 26(2):s191. Fidelman FN, Kerlan KR, Taylor TA, Kolli KK, Kohi KM, Hawkins HR, Pampaloni PM, Atreya AC, Bergsland BE, Kelley KR, Ko KA, Korn KW, Van Loon VK, Luan LJ, McWhirter MR, Johanson JC, Venook VA. .
      View in: Publisher Site   Mentions:
    3. 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study. J Gastrointest Cancer. 2014 Jun; 45(2):168-80. Fidelman N, Kerlan RK, Hawkins RA, Taylor AG, Kohi MP, Kolli KP, Bergsland EK, Kelley RK, Ko AH, Korn WM, McWhirter RM, Luan J, Venook AP. PMID: 24448917.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    4. Pharmacodynamic and efficacy analysis of the BRAF inhibitor dabrafenib (GSK436) in combination with the MEK inhibitor trametinib (GSK212) in patients with BRAFV600 mutant colorectal cancer (CRC). Journal of Clinical Oncology. 2013 May 20; 31(15_suppl):3507-3507. Corcoran CR, Falchook FG, Infante IJ, Hamid HO, Messersmith MW, Daud DA, Kwak KE, Ryan RD, Kurzrock KR, Atreya AC, Luan LJ, Sun SP, Schaeffer SM, Motwani MM, Bleam BM, Moy MC, Patel PK, Orford OK, Kopetz KS, Venook VA. .
      View in: Publisher Site   Mentions:
    5. Association of pyrexia and durable response in advanced melanoma patients treated with the combination of dabrafenib and trametinib. Journal of Clinical Oncology. 2012 May 20; 30(15_suppl):e19046-e19046. Cha CE, Kantor KA, Algazi AA, Hwang HJ, Luan LJ, Venook VA, Ziani ZL, Little LS, Patel PK, Daud DA. .
      View in: Publisher Site   Mentions:
    6. BRAF V600 mutant colorectal cancer (CRC) expansion cohort from the phase I/II clinical trial of BRAF inhibitor dabrafenib (GSK2118436) plus MEK inhibitor trametinib (GSK1120212). Journal of Clinical Oncology. 2012 May 20; 30(15_suppl):3528-3528. Corcoran CR, Falchook FG, Infante IJ, Hamid HO, Messersmith MW, Kwak KE, Ryan RD, Kurzrock KR, Brenner BA, Luan LJ, Sun SP, Allred AA, Little LS, Patel PK, Kopetz KS, Venook VA. .
      View in: Publisher Site   Mentions:
    7. Self-assessed sleep quality in chronic kidney disease. Int Urol Nephrol. 2005; 37(1):159-65. Kurella M, Luan J, Lash JP, Chertow GM. PMID: 16132780.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    8. Validation of the Kidney Disease Quality of Life (KDQOL) cognitive function subscale. Kidney Int. 2004 Dec; 66(6):2361-7. Kurella M, Luan J, Yaffe K, Chertow GM. PMID: 15569327.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    9. Cognitive impairment in chronic kidney disease. J Am Geriatr Soc. 2004 Nov; 52(11):1863-9. Kurella M, Chertow GM, Luan J, Yaffe K. PMID: 15507063.
      View in: PubMed   Mentions: 155     Fields:    Translation:Humans
    Jennifer's Networks
    Concepts (41)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (12)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-880-g43f982f8 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California